What is the level of liabilities of Nxera Pharma Co this year?
Nxera Pharma Co has a debt balance of 90.39 B JPY this year.
In 2024, Nxera Pharma Co's total liabilities amounted to 90.39 B JPY, a 117.9% difference from the 41.48 B JPY total liabilities in the previous year.
Nxera Pharma Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Nxera Pharma Co's financial stability, operational efficiency, and long-term viability.
By comparing Nxera Pharma Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Nxera Pharma Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Shifts in Nxera Pharma Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Nxera Pharma Co has a debt balance of 90.39 B JPY this year.
The liabilities of Nxera Pharma Co have increased by 117.9% increased compared to the previous year.
High liabilities can pose a risk for investors of Nxera Pharma Co, as they can weaken the company's financial position and impair its ability to meet its obligations.
Low liabilities mean that Nxera Pharma Co has a strong financial position and is able to meet its obligations without overburdening its finances.
An increase in liabilities of Nxera Pharma Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
A decrease in the liabilities of Nxera Pharma Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
Some factors that can influence the liabilities of Nxera Pharma Co include investments, acquisitions, operating costs, and sales development.
The liabilities of Nxera Pharma Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
To change its liabilities, Nxera Pharma Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
Over the past 12 months, Nxera Pharma Co paid a dividend of 2.5 JPY . This corresponds to a dividend yield of about 0.23 %. For the coming 12 months, Nxera Pharma Co is expected to pay a dividend of 0 JPY.
The current dividend yield of Nxera Pharma Co is 0.23 %.
Nxera Pharma Co pays a quarterly dividend. This is distributed in the months of .
Nxera Pharma Co paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.
Nxera Pharma Co is assigned to the 'Health' sector.
To receive the latest dividend of Nxera Pharma Co from 6/24/2015 amounting to 10 JPY, you needed to have the stock in your portfolio before the ex-date on 3/27/2015.
The last dividend was paid out on 6/24/2015.
In the year 2023, Nxera Pharma Co distributed 0 JPY as dividends.
The dividends of Nxera Pharma Co are distributed in JPY.
Our stock analysis for Nxera Pharma Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nxera Pharma Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.